NKE: -10% | Nike shares are trading lower after the company reported Q3 financial results. Also, the company issued Q4 sales guidance below estimates.

 

ORIC: -36% | Oric Pharmaceuticals shares are trading lower after the company announced an update from the Phase 1b trial of rinzimetostat in combination with darolutamide in patients with metastatic castration-resistant prostate cancer.

 

RH: -19% | RH shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 sales guidance below estimates.